Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2020 Filed May 14, 2020 17:26 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
PurchaseCommon Stock | 3,225 | $7.75 | $24,993.75 |
DisclosureSEC source: 0001209191-20-029243 · doc4.xml · nonDerivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,007 Read SEC document |
| May 14, 2020 Filed May 14, 2020 17:29 UTC |
NEWELL WILLIAM JDirector · CEO
|
PurchaseCommon Stock | 64,516 | $7.75 | $499,999.00 |
DisclosureSEC source: 0001209191-20-029246 · doc4.xml · nonDerivative · entry 1 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,627 Read SEC document |
| May 14, 2020 Filed May 14, 2020 21:27 UTC |
MOLINA ARTURO MDChief Medical Officer
|
PurchaseCommon Stock | 6,451 | $7.75 | $49,995.25 |
DisclosureSEC source: 0001209191-20-029244 · doc4.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,083 Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 20:24 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stocck | 2 | $11.19 | $22.38 |
DisclosureSEC source: 0001209191-20-025882 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,690 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 20:24 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 973 | $9.41 | $9,160.50 |
DisclosureSEC source: 0001209191-20-025882 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,692 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2020 Filed Mar 27, 2020 17:32 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $9.69 | $9,452.53 |
DisclosureSEC source: 0001209191-20-021438 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,665 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.34 to $9.885 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 17:34 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $10.47 | $10,207.28 |
DisclosureSEC source: 0001209191-20-013478 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,640 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.13 to $10.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:15 UTC |
Shabbir AnikChief Technical Ops. Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005806 · doc4.xml · derivative · entry 2 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2024-01-29 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:15 UTC |
Shabbir AnikChief Technical Ops. Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 41,250 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005806 · doc4.xml · derivative · entry 1 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 41,250 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:11 UTC |
ALBINI EDWARD CCFO and Secretary
|
GrantRestricted Stock Unit (RSU) · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005798 · doc4.xml · derivative · entry 2 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2024-01-29 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:11 UTC |
ALBINI EDWARD CCFO and Secretary
|
GrantStock Option (right to buy Common Stock) · Derivative | 47,500 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005798 · doc4.xml · derivative · entry 1 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:16 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005808 · doc4.xml · derivative · entry 2 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2024-01-29 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:16 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 66,250 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005808 · doc4.xml · derivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,250 Underlying: Common Stock · 66,250 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:20 UTC |
NEWELL WILLIAM JDirector · CEO
|
GrantRestricted Stock Unit (RSU) · Derivative | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005814 · doc4.xml · derivative · entry 5 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2024-01-29 F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F6 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:20 UTC |
NEWELL WILLIAM JDirector · CEO
|
GrantStock Option (right to buy Common Stock) · Derivative | 125,000 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005814 · doc4.xml · derivative · entry 4 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-01-29 F4 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:17 UTC |
Hallam TrevorChief Science Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005810 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2024-01-29 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:17 UTC |
Hallam TrevorChief Science Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 47,500 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005810 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 22:18 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005812 · doc4.xml · derivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2024-01-29 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 22:18 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 47,500 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0001209191-20-005812 · doc4.xml · derivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 16:48 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $10.51 | $10,250.37 |
DisclosureSEC source: 0001209191-20-005159 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,615 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.42 to $10.81 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 17:25 UTC |
PANEK JAMES PDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $12.02 | $0.00 |
DisclosureSEC source: 0001209191-20-002569 · doc4.xml · derivative · entry 1 PANEK JAMES P · CIK 0001217412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2030-01-07 F1 · derivative.exercise_date: The option vests as to 1/36th of the total shares monthly, beginning on February 7, 2020, with 100% of the total shares vested and exercisable on January 7, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 17:31 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $11.08 | $10,802.22 |
DisclosureSEC source: 0001209191-19-062036 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,590 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.83 to $11.29 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 16:50 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $10.68 | $10,410.27 |
DisclosureSEC source: 0001209191-19-058353 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,565 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.49 to $10.79 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 20:19 UTC |
Hallam TrevorChief Science Officer
|
SaleCommon Stock | 975 | $9.98 | $9,726.11 |
DisclosureSEC source: 0001209191-19-054572 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,540 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.44 to $10.11 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:19 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 8,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051117 · doc4.xml · derivative · entry 3 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,218 Underlying: Common Stock · 8,608 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:19 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Tax withholdingCommon Stock | 2,976 | $9.74 | $28,986.24 |
DisclosureSEC source: 0001209191-19-051117 · doc4.xml · nonDerivative · entry 2 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,632 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:19 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Exercise / conversionCommon Stock | 8,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051117 · doc4.xml · nonDerivative · entry 1 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:18 UTC |
ALBINI EDWARD CCFO and Secretary
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 7,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051116 · doc4.xml · derivative · entry 3 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,348 Underlying: Common Stock · 7,174 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:18 UTC |
ALBINI EDWARD CCFO and Secretary
|
Tax withholdingCommon Stock | 2,480 | $9.74 | $24,155.20 |
DisclosureSEC source: 0001209191-19-051116 · doc4.xml · nonDerivative · entry 2 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:18 UTC |
ALBINI EDWARD CCFO and Secretary
|
Exercise / conversionCommon Stock | 7,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051116 · doc4.xml · nonDerivative · entry 1 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:21 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 7,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051118 · doc4.xml · derivative · entry 4 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 Underlying: Common Stock · 7,575 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:21 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Tax withholdingCommon Stock | 2,619 | $9.74 | $25,509.06 |
DisclosureSEC source: 0001209191-19-051118 · doc4.xml · nonDerivative · entry 2 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,782 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:21 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionCommon Stock | 7,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051118 · doc4.xml · nonDerivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:26 UTC |
NEWELL WILLIAM JDirector · CEO
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 25,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051124 · doc4.xml · derivative · entry 5 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,505 Underlying: Common Stock · 25,252 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F7 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:26 UTC |
NEWELL WILLIAM JDirector · CEO
|
Tax withholdingCommon Stock | 13,219 | $9.74 | $128,753.06 |
DisclosureSEC source: 0001209191-19-051124 · doc4.xml · nonDerivative · entry 2 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,118 F2 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:26 UTC |
NEWELL WILLIAM JDirector · CEO
|
Exercise / conversionCommon Stock | 25,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051124 · doc4.xml · nonDerivative · entry 1 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Since the date of the reporting person's last ownership report, he transferred 94,085 shares of the issuer's common stock in a transfer exempt from Section 16. Following this transfer, the reporting person does not have voting or investment power over, or a pecuniary interest in, the transferred shares. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 6,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · derivative · entry 6 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887 Underlying: Common Stock · 6,887 shares Expires 2020-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/2 of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · derivative · entry 5 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,038 Underlying: Common Stock · 11,019 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Tax withholdingCommon Stock | 2,381 | $9.74 | $23,190.94 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · nonDerivative · entry 4 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,515 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Exercise / conversionCommon Stock | 6,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · nonDerivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Tax withholdingCommon Stock | 3,810 | $9.74 | $37,109.40 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,009 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:23 UTC |
Hallam TrevorChief Science Officer
|
Exercise / conversionCommon Stock | 11,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051119 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 21:25 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 8,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051122 · doc4.xml · derivative · entry 3 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,218 Underlying: Common Stock · 8,608 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 21:25 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Tax withholdingCommon Stock | 2,976 | $9.74 | $28,986.24 |
DisclosureSEC source: 0001209191-19-051122 · doc4.xml · nonDerivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,632 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 21:25 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 8,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051122 · doc4.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 21:43 UTC |
Petree Daniel HDirector
|
Exercise / conversionStock Option (right to buy Common Stock) · Derivative | 826 | $0.00 Strike: $5.09 | $0.00 |
DisclosureSEC source: 0001209191-19-048831 · doc4.xml · derivative · entry 3 Petree Daniel H · CIK 0001294939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 826 shares Expires 2019-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 21:43 UTC |
Petree Daniel HDirector
|
Exercise / conversionCommon Stock | 826 | $5.09 | $4,204.34 |
DisclosureSEC source: 0001209191-19-048831 · doc4.xml · nonDerivative · entry 1 Petree Daniel H · CIK 0001294939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2019 Filed Aug 29, 2019 18:46 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionStock Option (right to buy Common Stock) · Derivative | 826 | $0.00 Strike: $5.09 | $0.00 |
DisclosureSEC source: 0001209191-19-047755 · doc4.xml · derivative · entry 3 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 826 shares Expires 2019-09-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 29, 2019 Filed Aug 29, 2019 18:46 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionCommon Stock | 826 | $5.09 | $4,204.34 |
DisclosureSEC source: 0001209191-19-047755 · doc4.xml · nonDerivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:52 UTC |
MATSUI CONNIEDirector
|
GrantStock Option (right to buy Common Stock) · Derivative | 23,076 | $0.00 Strike: $11.68 | $0.00 |
DisclosureSEC source: 0001209191-19-039123 · doc4.xml · derivative · entry 1 MATSUI CONNIE · CIK 0001236537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,076 Underlying: Common Stock · 23,076 shares Expires 2029-06-24 F1 · derivative.exercise_date: The option vests as to 1/36th of the total shares monthly, beginning on July 24, 2019, with 100% of the total shares vested and exercisable on June 24, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.